LifeStance Health Group, Inc.
$6.92
▼
-0.94%
2026-04-21 07:52:01
lifestance.com
NMS: LFST
Explore LifeStance Health Group, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.69 B
Current Price
$6.92
52W High / Low
$8.09 / $3.74
Stock P/E
277.93
Book Value
$3.92
Dividend Yield
—
ROCE
1.24%
ROE
0.65%
Face Value
—
EPS
$0.02
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
10,961
Beta
1.13
Debt / Equity
31.2
Current Ratio
1.65
Quick Ratio
1.65
Forward P/E
16.74
Price / Sales
1.72
Enterprise Value
$2.72 B
EV / EBITDA
34.04
EV / Revenue
1.91
Rating
None
Target Price
$9.83
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | NewGenIvf Group Limited | $2.19 | 0.08 | $1.32 M | — | -135.35% | 79.4% | $7,356 / $1.52 | $110.5 |
| 2. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
| 3. | DocGo Inc. | $0.68 | — | $64.06 M | — | -59.59% | -89.05% | $2.45 / $0.49 | $1.46 |
| 4. | AMN Healthcare Services, Inc. | $20.46 | — | $790.91 M | — | 2.19% | -14.19% | $23.74 / $14.87 | $16.7 |
| 5. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 6. | Astrana Health, Inc. | $31.45 | 69.19 | $1.56 B | 0.51% | 4.9% | 4.49% | $34.8 / $18.08 | $15.94 |
| 7. | P3 Health Partners Inc. | $2.83 | — | $18.75 M | — | -242.67% | -69.53% | $11.3 / $1.52 | $-47.24 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 382.19 M | 363.81 M | 345.31 M | 332.97 M | 325.48 M | — |
| Operating Profit | 18.08 M | 7.41 M | -2.95 M | 1.6 M | 1.06 M | — |
| Net Profit | 11.67 M | 1.08 M | -3.79 M | 0.71 M | -7.11 M | — |
| EPS in Rs | 0.03 | 0 | -0.01 | 0 | -0.02 | -0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.42 B | 1.25 B | 1.06 B | 859.54 M |
| Operating Profit | 24.15 M | -31.61 M | -189.13 M | -210.17 M |
| Net Profit | 9.66 M | -57.44 M | -186.26 M | -215.56 M |
| EPS in Rs | 0.03 | -0.15 | -0.49 | -0.56 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.2 B | 2.12 B | 2.11 B | 2.17 B |
| Total Liabilities | 682.92 M | 672.01 M | 681.04 M | 655.15 M |
| Equity | 1.52 B | 1.45 B | 1.43 B | 1.52 B |
| Current Assets | 416.2 M | 312.51 M | 225.73 M | 233.22 M |
| Current Liabilities | 251.96 M | 228.89 M | 202.87 M | 176 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 146.15 M | 107.26 M | -16.88 M | 52.79 M |
| Investing CF | -36.12 M | -21.57 M | -60.34 M | -139.46 M |
| Financing CF | -15.96 M | -9.95 M | 47.43 M | 47.26 M |
| Free CF | 110.03 M | 85.69 M | -57.4 M | -26.47 M |
| Capex | -36.12 M | -21.57 M | -40.52 M | -79.25 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 18.5% | 22.82% | — | — |
| Earnings Growth % | 69.16% | 13.59% | — | — |
| Profit Margin % | -4.59% | -17.64% | -25.08% | — |
| Operating Margin % | -2.53% | -17.92% | -24.45% | — |
| Gross Margin % | 32.17% | 28.62% | 27.57% | — |
| EBITDA Margin % | 3.19% | -9.94% | -16.71% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.